Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B)
-
Published:2022-08
Issue:
Volume:171
Page:193-202
-
ISSN:0959-8049
-
Container-title:European Journal of Cancer
-
language:en
-
Short-container-title:European Journal of Cancer
Author:
Ozaki YukinoriORCID,
Tsurutani JunjiORCID,
Mukohara Toru,
Iwasa Tsutomu,
Takahashi MasatoORCID,
Tanabe Yuko,
Kawabata Hidetaka,
Masuda Norikazu,
Futamura Manabu,
Minami Hironobu,
Matsumoto Koji,
Yoshimura Kenichi,
Kitano ShigehisaORCID,
Takano ToshimiORCID
Subject
Cancer Research,Oncology
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献